Model Details

Patient Information for Model: BCM-15034

Patient Information
Clinical Timeline

Color Keys:
 Positive
 Negative
 N/A

Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection

Model Information for Model: BCM-15034

Biomarkers & Mutations
Model Details
Mutations
There are no omics data for this model.

CNV


Histology Information for Model: BCM-15034

Patient

PDX

ER

PR

HER2


Metastasis Information for Model: BCM-15034
 
Patient
PDX
Abdomen
Anterosuperior mediastinum
Bone
Brain
CTC
Chest
Chest wall
Contralateral breast
Fallopian tubes
Hip
Kidney
Leg bone
Liver
Lung
Lymph Node
Mediastinum
Neck
Other
Ovary
Pancreas
Paratracheal adenopathy
Pericardium
Peritoneal cavity
Peritoneum
Pleura
Pleural Cavitiy
Pleural effusion
Posterior cervical nodes
SVC node
Skin
Thymus

Patient Treatment Information for Model: BCM-15034

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponsePathologic ResponseReason Stopped
300[Letrozole]Adjuvant62.9963.0418 daysNot ReportedNot ApplicableSide Effects
307[Other]Recurrent/Metastatic63.0863.58183 daysNot ReportedDisease Progression
311[Paclitaxel]Recurrent/Metastatic63.6664.12168 daysNot ReportedDisease Progression
322[Everolimus, Exemestane]Recurrent/Metastatic64.1564.3366 daysNot ReportedDisease Progression
327[Capecitabine]Recurrent/Metastatic64.3364.4233 daysNot ReportedDisease Progression
331[Eribulin]Recurrent/Metastatic64.4364.5958 daysNot ReportedDisease Progression
341[Trastuzumab, Pertuzumab, Docetaxel]Recurrent/Metastatic64.6665.07150 daysCurrent Treatment
[Anastrozole, Palbociclib]Recurrent/Metastatic0.063.5823207 daysNot ReportedDisease Progression












Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.